Reports of clinical trials: Ethical aspects  by Sade, Robert M.
R
R
Sade Statistics for the Rest of Useports of clinical trials: Ethical aspects
obert M. Sade, MD
T ort-
i
e
j
s
h
t
r
j
t
o
w
M
e
c
s
c estiga-
t
m
 in
2
t
c
e
t
e
p
w
a
i
e
r
r
a
c
ST
A
TSFrom the Department of Surgery and the
Institute of Human Values in Health Care,
Medical University of South Carolina,
Charleston, SC.
Received for publication Oct 25, 2005; ac-
cepted for publication Mar 3, 2006.
Address for reprints: Robert M. Sade, MD,
Medical University of South Carolina, De-
partment of Surgery, 96 Jonathan Lucas St,
Suite 409, PO Box 250612, Charleston, SC
29425 (E-mail: sader@musc.edu).
J Thorac Cardiovasc Surg 2006;132:245-6
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgery
See related articles on pages
229, 233, 241, 243, 247, and 249.doi:10.1016/j.jtcvs.2006.03.042iruvoipati and colleagues1 have shown us glaring deficiencies in the rep
ing of randomized controlled trials (RCTs) in the cardiothoracic surgery
(CTS) literature. The CONSORT statement, a checklist and flowchart used
n writing reports of RCTs, is a tool that can be used to improve RCT reports; it is
ndorsed by most major medical journals but by none of the major cardiothoracic
ournals. Why is this? One reason might be that RCTs are not as applicable to
urgical as to medical disciplines. Indeed, the authors observe that RCTs are only
alf as prevalent in our journals as they are in general medical journals, and
herefore CTS journal editors might be less inclined to pay attention to quality of
eporting of low-incidence articles.
RCTs, the gold standard of clinical investigation, are less common in CTS
ournals than in medical journals for several reasons. Surgical clinical trial protocols
hat use no-treatment or placebo control groups are often not ethical, not desirable,
r both. Double blinding is usually not practicable because the surgeon must know
hat he or she is doing (although blinding of assessors and analysts can be done).
oreover, groups of patients in need of specific operations are often small and not
asily amenable to statistical analysis. Of greatest importance, however, is a special
haracteristic of surgical procedures: they are associated with a learning curve and
mall incremental improvements in technique that progressively improve out-
omes.2 Few of these limitations apply to drug trials and other medical inv
ions, and therefore we should not find it surprising that RCTs are more frequent in
edical than in surgical journals.
Nevertheless, Tiruvoipati and colleagues1 identified 62 RCTs in CTS journals
003. This is not a trivial number, and therefore perhaps it is time for CTS journals
o look more closely at the quality of the reports they publish. Accurate and
omplete reporting of relevant information arising from investigations benefits
veryone: physicians-investigators because they learn what will benefit their pa-
ients and what will not; the human patients-subjects because of fulfillment of their
xpectations that serving as experimental subjects will advance health care and
erhaps directly benefit themselves and that the risks they have taken have not been
asted; and future patients because they will be the beneficiaries of new information
bout drugs, methods, or operations. Conversely, inaccurate and incomplete report-
ng of clinical investigations harms those same individuals and groups.
Reporting of clinical investigations can be compromised in many ways. For
xample, industrial sponsors might erect barriers to publication of unfavorable
esults; investigators might design, execute, or analyze results of studies poorly or
eport results selectively; and journal reviewers and editors might overlook errors
nd deficiencies. Therefore the critical need for accurate and complete reporting of
linical investigations places certain burdens on individuals and institutions:
● sponsors must allow investigators freedom to report without bias or undue
influence whatever the investigator believes is relevant, whether positive or
negative and whether beneficial or harmful to product marketing;
● investigators must analyze their results objectively and report all relevant
information, including conclusions and recommendations that are justified by
the data, without overreaching and without understating;
● peer reviewers should evaluate the clarity and completeness of the report and
judge whether the conclusions and recommendations are justified by the data
reported; and
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TS● editors and editorial boards should use mechanisms
to ascertain freedom of investigators in reporting and
interpreting their data and encourage complete and
accurate reporting through use of tools such as the
CONSORT statement.
Forms of investigation other than RCTs might provide
eliable and useful new knowledge in CTS, such as
rospective uncontrolled clinical trials, retrospective ex-
mination of groups of patients or operations, and anal-
sis of large databases, such as the Society of Thoracic
urgeons’ National Database.3 The authors of a rece
tudy of RCTs in the CTS literature commented that “for
ost study questions in clinical surgery, comparative
nalysis of large case series and databases will provide
ore robust evidence” than RCTs.4 Like RCTs, such
nvestigations might be reported well or poorly, and it
ight be wise for CTS journal editors to consider devel-
ping and requiring adherence to checklists (perhaps
ased on CONSORT) for those reports as well. Certainly,
owever, the data reported by Tiruvoipati and col-
46 The Journal of Thoracic and Cardiovascular Surgery ● Augueagues1 make it incumbent on editors and edito
oards to assess critically their own practices regarding
eporting of RCTs and other human subject research and
o consider adopting the CONSORT statement for report-
ng RCTs. They should make any changes in their poli-
ies that seem likely to improve reporting of clinical
nvestigations.
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